Expression profiling of PPARγ-regulated MicroRNAs in human subcutaneous and visceral adipogenesis in both genders

Endocrinology

Volumn 155, Issue 6, 2014, Pages 2155-2165

  Yu, Jing ^a   Kong, Xiaocen ^a   Liu, Juan ^a   Lv, Yifan ^a   Sheng, Yunlu ^a   Lv, Shan ^a   Di, Wenjuan ^a   Wang, Chen ^a   Zhang, Feng ^a   Ding, Guoxian ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; BETA CATENIN; INSULIN; MICRORNA; MICRORNA 378; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA AGONIST; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1BETA; PIOGLITAZONE; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; WNT PROTEIN; TRANSCRIPTOME;

ADIPOCYTE; ADIPOGENESIS; ADULT; ARTICLE; BIOINFORMATICS; CELL CYCLE REGULATION; CONTROLLED STUDY; DRUG MECHANISM; FEMALE; GENDER; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE TARGETING; HUMAN; HUMAN CELL; HUMAN TISSUE; INTRAABDOMINAL FAT; INTRON; MALE; METABOLIC REGULATION; MICROARRAY ANALYSIS; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SUBCUTANEOUS TISSUE; UPREGULATION; AGONISTS; CELL CULTURE; CYTOLOGY; DRUG EFFECTS; GENETICS; METABOLISM; SUBCUTANEOUS FAT;

ADIPOCYTES; ADIPOGENESIS; CELLS, CULTURED; FEMALE; GENE EXPRESSION REGULATION; HUMANS; INTRA-ABDOMINAL FAT; MALE; MICRORNAS; PPAR GAMMA; SUBCUTANEOUS FAT; THIAZOLIDINEDIONES; TRANSCRIPTOME;

EID: 84901475804     PISSN: 00137227     EISSN: 19457170     Source Type: Journal    
DOI: 10.1210/en.2013-2105     Document Type: Article

References (36)

1. Siersbaek R, Nielsen R, Mandrup S. PPARγ in adipocyte differentiation and metabolism-novel insights from genome-wide studies. FEBS Lett. 2010;584(15): 3242-3249.
2. Miyazaki Y, Mahankali A, Matsuda M, et al. Effect of pioglitazone on abdominal fat distribution and insulin sensitivity in type 2 diabetic patients. J Clin Endocrinol Metab. 2002;87(6): 2784-2791.
3. Larsson B, Bjorntorp P, Tibblin G. The health consequences of moderate obesity. Int J Obes. 1981;5(2): 97-116.
4. Hubert HB, Feinleib M, McNamara PM, Castelli WP. Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study. Circulation. 1983;67(5): 968-977.
5. RexrodeKM, Hennekens CH, WillettWC, et al.Aprospective study of body mass index, weight change, and risk of stroke in women. JAMA. 1997;277(19): 1539-1545.
6. Tontonoz P, Hu E, Graves RA, Budavari AI, Spiegelman BM. mPPAR γ 2: tissue-specific regulator of an adipocyte enhancer. Genes Dev. 1994;8(10): 1224-1234.
7. de Souza CJ, Eckhardt M, Gagen K, et al. Effects of pioglitazone on adipose tissue remodeling within the setting of obesity and insulin resistance. Diabetes. 2001;50(8): 1863-1871.
8. Spiegelman BM. PPAR-γ: adipogenic regulator and thiazolidinedione receptor. Diabetes. 1998;47(4): 507-514.
9. Yessoufou A, Wahli W. Multifaceted roles of peroxisome proliferator-activated receptors (PPARs) at the cellular and whole organism levels. Swiss Med Wkly. 2010;140: w13071.
10. Janesick A, Blumberg B. Minireview: PPARγ as the target of obesogens. J Steroid Biochem Mol Biol. 2011;127(1-2): 4-8.
11. Ambros V. The functions of animal microRNAs. Nature. 2004; 431(7006): 350-355.
12. Chen CZ, Li L, Lodish HF, Bartel DP. MicroRNAs modulate hematopoietic lineage differentiation. Science. 2004;303(5654): 83-86.
13. Karp X, Ambros V. Developmental biology. Encountering microRNAs in cell fate signaling. Science. 2005;310(5752): 1288-1289.
14. Yi R, Poy MN, Stoffel M, Fuchs E. A skin microRNA promotes differentiation by repressing 'stemness'. Nature. 2008;452(7184): 225-229.
15. Xie H, Lim B, Lodish HF. MicroRNAs induced during adipogenesis that accelerate fat cell development are downregulated in obesity. Diabetes. 2009;58(5): 1050-1057.
16. Sun T, Fu M, Bookout AL, Kliewer SA, Mangelsdorf DJ. MicroRNA let-7 regulates 3T3-L1 adipogenesis. Mol Endocrinol. 2009;23(6): 925-931.
17. Tang YF, Zhang Y, Li XY, Li C, Tian W, Liu L. Expression of miR-31, miR-125b-5p, and miR-326 in the adipogenic differentiation process of adipose-derived stem cells. Omics : a journal of integrative biology. 2009;13(4): 331-336.
18. Esau C, Kang X, Peralta E, et al.MicroRNA-143regulates adipocyte differentiation. J Biol Chem. 2004;279(50): 52361-52365.
19. Lin Q, Gao Z, Alarcon RM, Ye J, Yun Z. A role of miR-27 in the regulation of adipogenesis. FEBS J. 2009;276(8): 2348-2358.
20. Kloting N, Berthold S, Kovacs P, et al. MicroRNA expression in human omental and subcutaneous adipose tissue. PloS One. 2009; 4(3): e4699.
21. Pandey DP, Picard D. Multidirectional interplay between nuclear receptors and microRNAs. Curr Opin Pharmacol. 2010;10(6): 637-642.
22. Card DA, Hebbar PB, Li L, et al. Oct4/Sox2-regulated miR-302 targets cyclin D1 in human embryonic stem cells. Mol Cell Biol. 2008;28(20): 6426-6438.
23. Bujalska IJ, Kumar S, Hewison M, Stewart PM. Differentiation of adipose stromal cells: the roles of glucocorticoids and 11β-hydroxysteroid dehydrogenase. Endocrinology. 1999;140(7): 3188-3196.
24. Adams M, Montague CT, Prins JB, et al. Activators of peroxisome proliferator-activated receptor -have depot-specific effects on human preadipocyte differentiation. J Clin Invest. 1997;100(12): 3149-3153.
25. Rosen ED, Sarraf P, Troy AE, et al. PPAR γ is required for the differentiation of adipose tissue in vivo and in vitro. Mol Cell. 1999;4 (4): 611-617.
26. Sewter CP, Blows F, Vidal-Puig A, O'Rahilly S. Regional differences in the response of human pre-adipocytes to PPARγ and RXR-agonists. Diabetes. 2002;51(3): 718-723.
27. Koenen TB, Tack CJ, Kroese JM, et al. Pioglitazone treatment enlarges subcutaneous adipocytes in insulin-resistant patients. J Clin Endocrinol Metab. 2009;94(11): 4453-4457.
28. Wei W, Wang X, Yang M, et al. PGC1β mediates PPARγ activation of osteoclastogenesis and rosiglitazone-induced bone loss. Cell Metab. 2010;11(6): 503-516.
29. Ji H, Lu RH, Chang ZG, Su SS, Yang GS. PGC-1β modulates the expression of genes involved in mitochondrial function and adipogenesis during preadipocyte differentiation. Reprod Domest Anim. 2012;47(3): 419-427.
30. Rayner KJ, Suá rez Y, Dávalos A, et al. MiR-33 contributes to the regulation of cholesterol homeostasis. Science. 2010;328(5985): 1570-1573.
31. Poy MN, Eliasson L, Krutzfeldt J, et al. A pancreatic islet-specific microRNA regulates insulin secretion. Nature. 2004;432(7014): 226-230.
32. Gauthier BR, Wollheim CB. MicroRNAs: 'ribo-regulators' of glucose homeostasis. Nat Med. 2006;12(1): 36-38.
33. Trajkovski M, Hausser J, Soutschek J, et al. MicroRNAs 103 and 107 regulate insulin sensitivity. Nature. 2011;474(7353): 649 -653.
34. Floyd ZE, Stephens JM. Controlling a master switch of adipocyte development and insulin sensitivity: covalent modifications of PPARγ. Biochim Biophys Acta. 2012;1822(7): 1090-1095.
35. Robbins GT, Nie D. PPAR β, bioactive lipids, and cancer progression. Front Biosci (Landmark Ed). 2012;17: 1816-1834.
36. Gerin I, Bommer GT, McCoin CS, Sousa KM, Krishnan V, Mac-Dougald OA. Roles for miRNA-378/378. in adipocyte gene expression and lipogenesis. Am J Physiol Endocrinol Metab. 2010;299(2): E198-E206.